开发和验证用于预测帕金森病患者骨质疏松症的机器学习模型
Yixin Liang1, Yiming Yin2, Kun Zhen3
1Department of Neurology, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210029, People's Republic of China.
Neuropsychiatric disease and treatment
|February 25, 2026
概括
机器学习模型可以使用常规临床数据预测帕金森病患者的骨质疏松症. 这些工具有助于针对性查和管理这个人群的骨折风险.
科学领域:
- 神经学 神经学
- 生物医学信息学 生物医学信息学
- 老年病的医生 老年病的医生
背景情况:
- 骨质疏松症是帕金森病 (PD) 的一个重大问题,增加骨折风险.
- 在PD患者中精确预测骨质疏松症对于及时干预至关重要.
- 现有的风险评估工具可能无法完全捕捉PD的复杂性.
研究的目的:
- 开发和外部验证用于预测帕金森病患者骨质疏松症的机器学习 (ML) 模型.
- 用例行收集的临床和与治疗相关的变量用于模型开发.
- 在不同的队列中评估ML模型的性能和临床实用性.
主要方法:
- 组建了一个3935名PD患者的多中心回顾队列,其中907名 (23.1%) 被诊断为骨质疏松症.
- 九个ML分类器被训练使用预测因素,包括人口统计,生活方式,并发症,PD严重程度和药物.
- 模型性能使用AUC,校准图和决策曲线分析进行评估,并使用SHAP进行解释性.
主要成果:
- 机器学习模型在开发,内部和外部验证队列中展示了中等到高的歧视和有利的校准.
- 一个神经网络模型实现了最高的性能 (AUC = 0.937),支持矢量机和随机森林也显示了强的结果 (AUC = 0.935).
- 关键预测因素包括较低的BMI,较高的Hoehn-Yahr阶段,较长的PD持续时间,先前的骨折,家族病史,肉症和特定药物的使用.
结论:
- 使用常规可用的临床数据的机器学习模型为PD患者的骨质疏松症提供了有效的风险分层.
- 这些模型表现出良好的校准和显著的临床实用性,支持有针对性的查.
- 开发的工具可以帮助制定个性化的管理策略,以减少这个脆弱人群中骨折风险.
更多相关视频
10:28Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
16.4K
07:12Semiautomated Longitudinal Microcomputed Tomography-based Quantitative Structural Analysis of a Nude Rat Osteoporosis-related Vertebral Fracture Model
Published on: September 28, 2017
8.7K
相关概念视频
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
